Virtual Medicinal Product (VMP) - Testosterone 2% transdermal gel (10mg per actuation)

Name Details

Name Start Date End Date
Name Current Name Testosterone 2% transdermal gel (10mg per actuation) Start Date 01-11-2023 End Date
Previous Name Previous Name Testosterone 2% gel (10mg per actuation) Start Date 30-07-2015 End Date 31-10-2023

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
0.5
UDFS UOM
gram
Unit Dose UOM
actuation

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
Schedule 4 (CD Anab)
Route
Transdermal
Form
Transdermal gel
Ontology Form/Route
gel.transdermal
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
G03BA03
BNF Start Date End Date
Current BNF 06040200 Start Date 04-04-2022 End Date
Previous BNF 06040200 Start Date 09-05-2008 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
11564011000001106 18-06-2007

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Testosterone Based on Ingredient Substance 20 mg 1 gram

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
60 gram 2863 Part VIIIA Category C
180 gram